These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28603040)

  • 41. Influence of ionic strength, pH and aptamer configuration for binding affinity to thrombin.
    Hianik T; Ostatná V; Sonlajtnerova M; Grman I
    Bioelectrochemistry; 2007 Jan; 70(1):127-33. PubMed ID: 16725379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duplexed aptamers: history, design, theory, and application to biosensing.
    Munzar JD; Ng A; Juncker D
    Chem Soc Rev; 2019 Mar; 48(5):1390-1419. PubMed ID: 30707214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duplex-quadruplex motifs in a peculiar structural organization cooperatively contribute to thrombin binding of a DNA aptamer.
    Russo Krauss I; Pica A; Merlino A; Mazzarella L; Sica F
    Acta Crystallogr D Biol Crystallogr; 2013 Dec; 69(Pt 12):2403-11. PubMed ID: 24311581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NMR resonance assignments for the tetramethylrhodamine binding RNA aptamer 3 in complex with the ligand 5-carboxy-tetramethylrhodamine.
    Duchardt-Ferner E; Juen M; Kreutz C; Wöhnert J
    Biomol NMR Assign; 2017 Apr; 11(1):29-34. PubMed ID: 27730489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute quantification of cell-bound DNA aptamers during SELEX.
    Avci-Adali M; Wilhelm N; Perle N; Stoll H; Schlensak C; Wendel HP
    Nucleic Acid Ther; 2013 Apr; 23(2):125-30. PubMed ID: 23405949
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Post-ExSELEX stabilization of an unnatural-base DNA aptamer targeting VEGF165 toward pharmaceutical applications.
    Kimoto M; Nakamura M; Hirao I
    Nucleic Acids Res; 2016 Sep; 44(15):7487-94. PubMed ID: 27387284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Construction of synthetic promoters for Escherichia coli and application in the biosynthesis of cis,cis-muconic acid].
    Wu Y; Zhang Y; Tu R; Liu H; Wang Q
    Sheng Wu Gong Cheng Xue Bao; 2013 Jun; 29(6):760-71. PubMed ID: 24063236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L-pipecolic acid in Escherichia coli.
    Ying H; Tao S; Wang J; Ma W; Chen K; Wang X; Ouyang P
    Microb Cell Fact; 2017 Mar; 16(1):52. PubMed ID: 28347340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability and binding properties of a modified thrombin binding aptamer.
    Pagano B; Martino L; Randazzo A; Giancola C
    Biophys J; 2008 Jan; 94(2):562-9. PubMed ID: 17890401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Engineering a structure switching mechanism into a steroid-binding aptamer and hydrodynamic analysis of the ligand binding mechanism.
    Reinstein O; Neves MA; Saad M; Boodram SN; Lombardo S; Beckham SA; Brouwer J; Audette GF; Groves P; Wilce MC; Johnson PE
    Biochemistry; 2011 Nov; 50(43):9368-76. PubMed ID: 21942676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic pathway regulation: recent advances and methods of construction.
    Tan SZ; Prather KL
    Curr Opin Chem Biol; 2017 Dec; 41():28-35. PubMed ID: 29059607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A simple method for eliminating fixed-region interference of aptamer binding during SELEX.
    Ouellet E; Lagally ET; Cheung KC; Haynes CA
    Biotechnol Bioeng; 2014 Nov; 111(11):2265-79. PubMed ID: 24895227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aptamer selection by high-throughput sequencing and informatic analysis.
    Hoon S; Zhou B; Janda KD; Brenner S; Scolnick J
    Biotechniques; 2011 Dec; 51(6):413-6. PubMed ID: 22150332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel application of fluorescence coupled capillary electrophoresis to resolve the interaction between the G-quadruplex aptamer and thrombin.
    Wang J; Gu Y; Liu L; Wang C; Wang J; Ding S; Li J; Qiu L; Jiang P
    J Sep Sci; 2017 Aug; 40(15):3161-3167. PubMed ID: 28594110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids.
    Meek KN; Rangel AE; Heemstra JM
    Methods; 2016 Aug; 106():29-36. PubMed ID: 27012179
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mode of action of the TyrR protein: repression and activation of the tyrP promoter of Escherichia coli.
    Yang J; Hwang JS; Camakaris H; Irawaty W; Ishihama A; Pittard J
    Mol Microbiol; 2004 Apr; 52(1):243-56. PubMed ID: 15049824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An inhibitory RNA aptamer against the lambda cI repressor shows transcriptional activator activity in vivo.
    Ohuchi S; Suess B
    FEBS Lett; 2017 May; 591(10):1429-1436. PubMed ID: 28407231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cell-SELEX Based Identification of an RNA Aptamer for
    Dua P; Ren S; Lee SW; Kim JK; Shin HS; Jeong OC; Kim S; Lee DK
    Mol Cells; 2016 Nov; 39(11):807-813. PubMed ID: 27871171
    [No Abstract]   [Full Text] [Related]  

  • 59. Tuning riboswitch-mediated gene regulation by rational control of aptamer ligand binding properties.
    Rode AB; Endoh T; Sugimoto N
    Angew Chem Int Ed Engl; 2015 Jan; 54(3):905-9. PubMed ID: 25470002
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Building an RNA-Based Toggle Switch Using Inhibitory RNA Aptamers.
    Climent-Catala A; Ouldridge TE; Stan GV; Bae W
    ACS Synth Biol; 2022 Feb; 11(2):562-569. PubMed ID: 35133150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.